Molina Healthcare Inc (MOH)

Return on equity (ROE)

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net income (ttm) US$ in thousands 1,179,000 1,144,000 1,063,000 1,071,000 1,091,000 931,000 916,000 855,000 792,000 839,000 752,000 689,000 659,000 590,000 632,000 723,000 673,000 807,000 797,000 717,000
Total stockholders’ equity US$ in thousands 4,496,000 4,770,000 4,843,000 4,493,000 4,215,000 3,879,000 3,621,000 3,288,000 2,964,000 3,041,000 2,830,000 2,794,000 2,630,000 2,518,000 2,370,000 2,164,000 2,096,000 2,201,000 1,996,000 1,647,000
ROE 26.22% 23.98% 21.95% 23.84% 25.88% 24.00% 25.30% 26.00% 26.72% 27.59% 26.57% 24.66% 25.06% 23.43% 26.67% 33.41% 32.11% 36.67% 39.93% 43.53%

December 31, 2024 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $1,179,000K ÷ $4,496,000K
= 26.22%

Molina Healthcare Inc's return on equity (ROE) has experienced a gradual decline over the analyzed period from March 31, 2020, to December 31, 2024.

Starting at a robust 43.53% in March 2020, the ROE steadily decreased to 26.22% by December 2024. Despite some fluctuations, the general trend indicates a decreasing profitability efficiency in generating returns for its shareholders' equity.

The fluctuations in ROE over the period suggest that Molina Healthcare Inc may be facing challenges in effectively utilizing its equity to generate profits. Investors and analysts may want to investigate the reasons behind the declining trend in ROE to determine the company's overall financial health and performance.